Non-Hodgkin Lymphoma Following Temozolomide

被引：11

作者：

Sharma, Atul ^{[1
]}

Gupta, Deepak ^{[1
]}

Mohanti, B. K. ^{[2
]}

Thulkar, Sanjay ^{[3
]}

Dwary, Amit ^{[1
]}

Goyal, Shikha ^{[2
]}

Muzumder, Sandeep ^{[2
]}

Das, Prasenjit ^{[4
]}

机构：

[1] All India Inst Med Sci, Dr BRA IRCH, Dept Med Oncol, New Delhi 110029, India

[2] All India Inst Med Sci, Dr BRA IRCH, Dept Radiat Oncol, New Delhi 110029, India

[3] All India Inst Med Sci, Dr BRA IRCH, Dept Radiodiag, New Delhi 110029, India

[4] All India Inst Med Sci, Dr BRA IRCH, Dept Pathol, New Delhi 110029, India

来源：

PEDIATRIC BLOOD & CANCER | 2009年 / 53卷 / 04期

关键词：

glioblastoma multiforme; temozolomide; second malignancy; non-Hodgkin lymphoma;

D O I：

10.1002/pbc.22090

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Temozolomide (TMZ) is an oral alkylating agent with significant activity against glioblastoma multiforme (GBM) and melanoma. It increases survival by 2.5 months when used in combination with radiotherapy as an adjuvant therapy in GBM. Secondary MDS/AML or non-Hodgkin lymphoma attributed to TMZ exposure has been reported. We report a case of non-Hodgkin lymphoma secondary to temozolomide in a 20-year-old female who was treated for GBM with concurrent TMZ and radiotherapy. She developed lymphoma 2 months after completing chemoradiotherapy. Although she was treated with combination chemotherapy for lymphoma, she died of progressive GBM. Pediatr Blood Cancer 2009;53: 661-662. (C) 2009 Wiley-Lis, Inc.

引用

页码：661 / 662

页数：2

共 50 条

[1] Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide
Broes, K.
Van Ginderachter, L.
Joosens, E.
Maes, A.
Theunissen, K.
Schepers, S.
Deben, K.
Claes, J.
Mebis, J.
Cox, T.
B-ENT, 2015, 11 (01): : 73 - 76
[2] Non-Hodgkin's lymphoma in a patient on treatment with temozolomide
Otty, Zulfiquer
Sabesan, Sabe
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (04) : E53 - E54
[3] Discitis following lumbar puncture in non-Hodgkin lymphoma
Yazici, N
Yalçin, B
Cila, A
Alnay, A
Büyükpamukçu, M
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2005, 22 (08) : 689 - 694
[4] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Bei Hu
Ryan Jacobs
Nilanjan Ghosh
Current Hematologic Malignancy Reports, 2018, 13 : 543 - 554
[5] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Hu, Bei
Jacobs, Ryan
Ghosh, Nilanjan
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 543 - 554
[6] PULMONARY NON-HODGKIN LYMPHOMA
SABIDO, RC
ANGELES, AA
NAVARRO, F
DELVALLE, RB
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1991, 43 (01): : 68 - 71
[7] Non-Hodgkin lymphoma of the breast
Ganjoo, Kristen
Advani, Ranjana
Mariappan, M. Rajan
McMillan, Alex
Horning, Sandra
CANCER, 2007, 110 (01) : 25 - 30
[8] Transplantation for non-Hodgkin lymphoma
Nademanee, Auayporn
EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (04) : 425 - 442
[9] The epidemiology of non-Hodgkin lymphoma
Grulich, AE
Vajdic, CM
PATHOLOGY, 2005, 37 (06) : 409 - 419
[10] Immunohistochemical Profile of Hodgkin and Non-Hodgkin Lymphoma
Shahid, Ruqaiya
Gulzar, Rubina
Avesi, Lubna
Hassan, Saba
Danish, Farheen
Mirza, Talat
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (02): : 103 - 107

← 1 2 3 4 5 →